293 related articles for article (PubMed ID: 17041717)
1. Infusion of autologous retrodifferentiated stem cells into patients with beta-thalassemia.
Abuljadayel IS; Quereshi H; Ahsan T; Rizvi S; Ahmed T; Khan SM; Akhtar J; Dhoot G
ScientificWorldJournal; 2006 Oct; 6():1278-97. PubMed ID: 17041717
[TBL] [Abstract][Full Text] [Related]
2. Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia.
Thompson AA; Walters MC; Kwiatkowski J; Rasko JEJ; Ribeil JA; Hongeng S; Magrin E; Schiller GJ; Payen E; Semeraro M; Moshous D; Lefrere F; Puy H; Bourget P; Magnani A; Caccavelli L; Diana JS; Suarez F; Monpoux F; Brousse V; Poirot C; Brouzes C; Meritet JF; Pondarré C; Beuzard Y; Chrétien S; Lefebvre T; Teachey DT; Anurathapan U; Ho PJ; von Kalle C; Kletzel M; Vichinsky E; Soni S; Veres G; Negre O; Ross RW; Davidson D; Petrusich A; Sandler L; Asmal M; Hermine O; De Montalembert M; Hacein-Bey-Abina S; Blanche S; Leboulch P; Cavazzana M
N Engl J Med; 2018 Apr; 378(16):1479-1493. PubMed ID: 29669226
[TBL] [Abstract][Full Text] [Related]
3. Hemoglobin disorders: lentiviral gene therapy in the starting blocks to enter clinical practice.
Sii-Felice K; Giorgi M; Leboulch P; Payen E
Exp Hematol; 2018 Aug; 64():12-32. PubMed ID: 29807062
[TBL] [Abstract][Full Text] [Related]
4. New therapeutic targets in transfusion-dependent and -independent thalassemia.
Cappellini MD; Motta I
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):278-283. PubMed ID: 29222267
[TBL] [Abstract][Full Text] [Related]
5. Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia.
Locatelli F; Lang P; Wall D; Meisel R; Corbacioglu S; Li AM; de la Fuente J; Shah AJ; Carpenter B; Kwiatkowski JL; Mapara M; Liem RI; Cappellini MD; Algeri M; Kattamis A; Sheth S; Grupp S; Handgretinger R; Kohli P; Shi D; Ross L; Bobruff Y; Simard C; Zhang L; Morrow PK; Hobbs WE; Frangoul H;
N Engl J Med; 2024 May; 390(18):1663-1676. PubMed ID: 38657265
[TBL] [Abstract][Full Text] [Related]
6. One-step genetic correction of hemoglobin E/beta-thalassemia patient-derived iPSCs by the CRISPR/Cas9 system.
Wattanapanitch M; Damkham N; Potirat P; Trakarnsanga K; Janan M; U-Pratya Y; Kheolamai P; Klincumhom N; Issaragrisil S
Stem Cell Res Ther; 2018 Feb; 9(1):46. PubMed ID: 29482624
[TBL] [Abstract][Full Text] [Related]
7. Recent Progress in Gene Therapy and Other Targeted Therapeutic Approaches for Beta Thalassemia.
Hamed EM; Meabed MH; Aly UF; Hussein RRS
Curr Drug Targets; 2019; 20(16):1603-1623. PubMed ID: 31362654
[TBL] [Abstract][Full Text] [Related]
8. Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia.
Marktel S; Scaramuzza S; Cicalese MP; Giglio F; Galimberti S; Lidonnici MR; Calbi V; Assanelli A; Bernardo ME; Rossi C; Calabria A; Milani R; Gattillo S; Benedicenti F; Spinozzi G; Aprile A; Bergami A; Casiraghi M; Consiglieri G; Masera N; D'Angelo E; Mirra N; Origa R; Tartaglione I; Perrotta S; Winter R; Coppola M; Viarengo G; Santoleri L; Graziadei G; Gabaldo M; Valsecchi MG; Montini E; Naldini L; Cappellini MD; Ciceri F; Aiuti A; Ferrari G
Nat Med; 2019 Feb; 25(2):234-241. PubMed ID: 30664781
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of advanced glycation end products positively correlate with iron overload and oxidative stress markers in patients with β-thalassemia major.
Mirlohi MS; Yaghooti H; Shirali S; Aminasnafi A; Olapour S
Ann Hematol; 2018 Apr; 97(4):679-684. PubMed ID: 29318368
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral Transfer of γ-Globin with Fusion Gene NUP98-HOXA10HD Expands Hematopoietic Stem Cells and Ameliorates Murine β-Thalassemia.
Zhao HF; Abraham A; Kim YS; Wang YD; Pestina T; Zhan J; Humphries K; Nienhuis AW; Persons DA
Mol Ther; 2017 Mar; 25(3):593-605. PubMed ID: 28190779
[TBL] [Abstract][Full Text] [Related]
11. Alpha- and Beta-thalassemia: Rapid Evidence Review.
Baird DC; Batten SH; Sparks SK
Am Fam Physician; 2022 Mar; 105(3):272-280. PubMed ID: 35289581
[TBL] [Abstract][Full Text] [Related]
12. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.
Perrine SP; Ginder GD; Faller DV; Dover GH; Ikuta T; Witkowska HE; Cai SP; Vichinsky EP; Olivieri NF
N Engl J Med; 1993 Jan; 328(2):81-6. PubMed ID: 7677966
[TBL] [Abstract][Full Text] [Related]
13. Alpha and beta thalassemia.
Muncie HL; Campbell J
Am Fam Physician; 2009 Aug; 80(4):339-44. PubMed ID: 19678601
[TBL] [Abstract][Full Text] [Related]
14. Beta-thalassemia.
Cao A; Galanello R
Genet Med; 2010 Feb; 12(2):61-76. PubMed ID: 20098328
[TBL] [Abstract][Full Text] [Related]
15. HbF in HbE/β-thalassemia: A clinical and laboratory correlation.
Lim WF; Muniandi L; George E; Sathar J; Teh LK; Lai MI
Hematology; 2015 Jul; 20(6):349-53. PubMed ID: 25243862
[TBL] [Abstract][Full Text] [Related]
16. [γ-Globin Inductive Therapy of β-thalassemia and Its Relationship with MicroRNA].
Li YY; Gu J; Yu DN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):627-31. PubMed ID: 27151042
[TBL] [Abstract][Full Text] [Related]
17. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia.
Embury SH; Dozy AM; Miller J; Davis JR; Kleman KM; Preisler H; Vichinsky E; Lande WN; Lubin BH; Kan YW; Mentzer WC
N Engl J Med; 1982 Feb; 306(5):270-4. PubMed ID: 6172710
[TBL] [Abstract][Full Text] [Related]
18. Preclinical transfusion-dependent humanized mouse model of beta thalassemia major.
Huo Y; McConnell SC; Ryan TM
Blood; 2009 May; 113(19):4763-70. PubMed ID: 19258591
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant status in beta thalassemia major: a single-center study.
Waseem F; Khemomal KA; Sajid R
Indian J Pathol Microbiol; 2011; 54(4):761-3. PubMed ID: 22234105
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]